Showing results (1161-1170 of 16,809) with videos related to
Sort By:
Pageof 1,681
British Journal of Haematology|October 16, 1999
Influence of three potential genetic risk factors for thrombosis in 43 families carrying the factor V Arg 506 to Gln mutationV Le Cam-Duchez, S Gandrille, D Trégouët, et al.British Journal of Haematology|October 16, 1999
An in vitro system for expression analysis of mutations of the beta-globin gene: validation and application to two mutations in the 5' UTRP J Ho, J Sloane-Stanley, A Athanassiadou, et al.British Journal of Haematology|October 16, 1999
Persistent leucocyte abnormalities in children years after previous long-term low-dose radiation exposureW P Chang, Y P Lin, P T Hwang, et al.British Journal of Haematology|May 8, 1999
Expansion and differentiation of haemopoietic progenitor cells on endothelialized hydroxyapatite under static conditionsV Conrad, M Dupouy, L Bordenave, et al.British Journal of Haematology|May 8, 1999
A case of complete adenylate kinase deficiency due to a nonsense mutation in AK-1 gene (Arg 107 --> Stop, CGA --> TGA) associated with chronic haemolytic anaemiaP Bianchi, M Zappa, E Bredi, et al.British Journal of Haematology|May 8, 1999
Detection of GPI-anchored protein-deficient cells in patients with aplastic anaemia and evidence for clonal expansion during the clinical courseK Kawaguchi, H Wada, A Mori, et al.British Journal of Haematology|May 8, 1999
Paraproteins and monoclonal expansion of CD3+CD8+ CD56-CD57+ T lymphocytes in a patient with HIV infectionP Smith, M Helbert, M Raftery, et al.British Journal of Haematology|May 8, 1999
Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodiesM Zhu, T Olee, D T Le, et al.British Journal of Haematology|May 8, 1999
Inadequacies in the postnatal management of fetomaternal alloimmune thrombocytopenia (FMAIT)M F Murphy, S Verjee, M GreavesBritish Journal of Haematology|May 8, 1999
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myelomaC M Segeren, P Sonneveld, B van der Holt, et al.Pageof 1,681